Amplifon upgrades earnings guidance despite flat revenue – ready for GN mega-merger

For the full year 2026, Amplifon expects organic growth of 3% and improved margins, while the focus remains on the integration of GN Hearing.

No actionable change — this is a corporate earnings and M&A update with no direct clinical implications.

The Amplifon–GN Hearing integration is one of the largest consolidations in the audiology retail and manufacturing sectors, with potential downstream effects on product availability and clinic competition.

1. 01Amplifon upgrades full-year 2026 earnings guidance despite flat revenue.
2. 02Company projects 3% organic growth and improved profit margins.
3. 03Integration of GN Hearing acquisition is ongoing.
4. 04Flat revenue alongside improved margins suggests cost management rather than volume growth.